| Date | Time | Source | Headline | Symbol | Company |
| 08/12/2009 | 4:32AM | Dow Jones News | AstraZeneca, Forest Labs Ink Ceftaroline Deal | NYSE:FRX | Forest Laboratories Inc. |
| 08/12/2009 | 4:00AM | Business Wire | Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:59AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:58AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:58AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:57AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:57AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:56AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/10/2009 | 2:31PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/10/2009 | 7:00AM | PR Newswire (US) | Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD | NYSE:FRX | |
| 08/10/2009 | 7:00AM | Business Wire | Nycomed and Forest Laboratories to Collaborate on Daxas® (roflumilast) for COPD | NYSE:FRX | Forest Road Acquisition Corp |
| 07/21/2009 | 5:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/21/2009 | 9:08AM | Dow Jones News | Forest Labs 1Q Net Up 8.2% As Namenda Sales Jump | NYSE:FRX | Forest Laboratories Inc. |
| 07/21/2009 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports Fiscal First Quarter 2010 Earnings Per Share of $0.87 | NYSE:FRX | Forest Road Acquisition Corp |
| 07/16/2009 | 6:00AM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/15/2009 | 7:04AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of EXH, GME, CAG, FRX, EXR and KEY | NYSE:FRX | Forest Road Acquisition Corp |
| 07/14/2009 | 9:48AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/10/2009 | 9:15AM | PR Newswire (US) | Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigat | NYSE:FRX | Forest Road Acquisition Corp |
| 07/06/2009 | 9:00AM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 07/01/2009 | 8:36AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on FRX, CF, LOW, STT, AIZ and DPS | NYSE:FRX | Forest Road Acquisition Corp |
| 07/01/2009 | 8:36AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on FRX, CF, LOW, STT, AIZ and DPS | NYSE:FRX | Forest Road Acquisition Corp |
| 06/30/2009 | 4:25PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/30/2009 | 4:25PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/22/2009 | 6:22PM | PR Newswire (US) | The Microcap Underground on Stocks to Watch: Oncothyreon Inc, Forest Labs, and Johnson & Johnson | NYSE:FRX | Forest Road Acquisition Corp |
| 06/22/2009 | 9:20AM | PR Newswire (US) | Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham | NYSE:FRX | |
| 06/19/2009 | 2:40PM | Dow Jones News | Forest Labs Reports Upbeat Pneumonia Drug Test Results | NYSE:FRX | Forest Laboratories Inc. |
| 06/19/2009 | 1:25PM | PR Newswire (US) | Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Commu | NYSE:FRX | Forest Road Acquisition Corp |
| 06/19/2009 | 12:38PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/17/2009 | 12:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/12/2009 | 9:31AM | PR Newswire (US) | Critical Alerts for SLB, S, BCS, WLT, and FRX Released by Seven Summits Research | NYSE:FRX | Forest Road Acquisition Corp |